Bay Street News, March 5th, 2020

CLBS16 ESCaPE-CMD data presented at American Heart Association 2019 Scientific Sessions demonstrated highly statistically significant improvement in coronary flow reserve […]

BURLINGAME, Calif., March 05, 2020 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company focused on the […]

– Grows Annual System-Wide Sales 33% and Comp Sales 25%, Compared to 2018 –– Increases Annual Net Income to $3.3 […]

Zafgen and Chondrial Therapeutics previously announced a definitive merger agreementMerger creates clinical-stage company focused on the development of novel protein […]

DENVER, March 05, 2020 (GLOBE NEWSWIRE) — Extraction Oil & Gas, Inc. (NASDAQ: XOG) (“Extraction” or the “Company”) today announced […]

OAKLAND, Calif., March 05, 2020 (GLOBE NEWSWIRE) — DASAN Zhone Solutions, Inc. (NASDAQ: DZSI or the “Company” or “DZS”), the […]

DENVER, March 05, 2020 (GLOBE NEWSWIRE) — Extraction Oil & Gas, Inc. (NASDAQ: XOG) (“Extraction” or the “Company”) today reported […]

Full Year 2019Service revenue of $621.9 millionIncome from operations of $18.1 millionAdjusted operating income(1) of $53.4 millionIncome before income taxes […]

DEER PARK, Ill., March 05, 2020 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on […]

CAMBRIDGE, Mass., March 05, 2020 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing [...]